Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
International Journal of Nephrology|March 12, 2013
Are the Mesothelial-to-Mesenchymal Transition, Sclerotic Peritonitis Syndromes, and Encapsulating Peritoneal Sclerosis Part of the Same Process?Jesús Loureiro, Guadalupe Gónzalez-Mateo, José Jimenez-Heffernan, et al.
Rheumatology (Oxford, England)|March 11, 2014
Mitochondrial dysfunction promotes and aggravates the inflammatory response in normal human synoviocytesMarta N Valcárcel-Ares, Romina R Riveiro-Naveira, Carlos Vaamonde-García, et al.
Journal of the American Society of Nephrology : JASN|July 12, 2014
A pathogenetic role for endothelin-1 in peritoneal dialysis-associated fibrosisOscar Busnadiego, Jesús Loureiro-Álvarez, Pilar Sandoval, et al.
Rheumatology (Oxford, England)|June 30, 2016
Resveratrol lowers synovial hyperplasia, inflammatory markers and oxidative damage in an acute antigen-induced arthritis modelRomina R Riveiro-Naveira, Marta N Valcárcel-Ares, Maylin Almonte-Becerril, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|December 17, 2008
Characterization of epithelial-to-mesenchymal transition of mesothelial cells in a mouse model of chronic peritoneal exposure to high glucose dialysateLuiz S Aroeira, Jesús Loureiro, Guadalupe T González-Mateo, et al.
BMC Musculoskeletal Disorders|June 14, 2017
The mitochondrial inhibitor oligomycin induces an inflammatory response in the rat knee jointCarlos Vaamonde-García, Jesús Loureiro, Marta N Valcárcel-Ares, et al.
EMBO Molecular Medicine|January 1, 2015
Caveolin-1 deficiency induces a MEK-ERK1/2-Snail-1-dependent epithelial-mesenchymal transition and fibrosis during peritoneal dialysisRaffaele Strippoli, Jesús Loureiro, Vanessa Moreno, et al.
Journal of the American Society of Nephrology : JASN|July 12, 2011
Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damageJesús Loureiro, Abelardo Aguilera, Rafael Selgas, et al.
Biomed Research International|December 22, 2015
Rapamycin Protects from Type-I Peritoneal Membrane Failure Inhibiting the Angiogenesis, Lymphangiogenesis, and Endo-MTGuadalupe Tirma González-Mateo, Anna Rita Aguirre, Jesús Loureiro, et al.
Pageof 2